Tumor-targeted metabolic inhibitor prodrug labelled with cyanine dyes enhances immunoprevention of lung cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor-targeted metabolic inhibitor prodrug labelled with cyanine dyes enhances immunoprevention of lung cancer
Authors
Keywords
-
Journal
Acta Pharmaceutica Sinica B
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2023-11-01
DOI
10.1016/j.apsb.2023.10.020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Photouncaging of Carboxylic Acids from Cyanine Dyes with Near‐Infrared Light**
- (2022) Hana Janeková et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Harnessing Radical‐Mediated Photocaged Cyanine under Hypoxia for in vivo Precision Drug Release
- (2021) Yutao Zhang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Cell-programmed nutrient partitioning in the tumour microenvironment
- (2021) Bradley I. Reinfeld et al. NATURE
- Targeting glutamine utilization to block metabolic adaptation of tumor cells under the stress of carboxyamidotriazole-induced nutrients unavailability
- (2021) Jing Shi et al. Acta Pharmaceutica Sinica B
- Targeting cancer metabolism in the era of precision oncology
- (2021) Zachary E. Stine et al. NATURE REVIEWS DRUG DISCOVERY
- Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma
- (2021) Danyu Du et al. Acta Pharmaceutica Sinica B
- Electromagnetic nanomedicines for combinational cancer immunotherapy
- (2020) Kanyi Pu et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs
- (2019) Lukáš Tenora et al. JOURNAL OF MEDICINAL CHEMISTRY
- We're Not “DON” Yet: Optimal Dosing and Prodrug Delivery of6-Diazo-5-oxo-L-norleucine
- (2018) Kathryn M. Lemberg et al. MOLECULAR CANCER THERAPEUTICS
- N-(Pivaloyloxy)alkoxy-carbonyl Prodrugs of the Glutamine Antagonist 6-Diazo-5-oxo-l-norleucine (DON) as a Potential Treatment for HIV Associated Neurocognitive Disorders
- (2017) Michael T. Nedelcovych et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of 6-Diazo-5-oxo-l-norleucine (DON) Prodrugs with Enhanced CSF Delivery in Monkeys: A Potential Treatment for Glioblastoma
- (2016) Rana Rais et al. JOURNAL OF MEDICINAL CHEMISTRY
- Searching for Improved Photoreleasing Abilities of Organic Molecules
- (2015) Tomáš Šolomek et al. ACCOUNTS OF CHEMICAL RESEARCH
- Photoremovable Protecting Groups in Chemistry and Biology: Reaction Mechanisms and Efficacy
- (2012) Petr Klán et al. CHEMICAL REVIEWS
- The Common Feature of Leukemia-Associated IDH1 and IDH2 Mutations Is a Neomorphic Enzyme Activity Converting α-Ketoglutarate to 2-Hydroxyglutarate
- (2010) Patrick S. Ward et al. CANCER CELL
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started